A Lampen

Publications (2)1.32 Total impact

• Article: [Current aspects in risk assessment of allergen traces in foodstuffs].

  K Richter, D Rubin, A Lampen
  [show abstract] [hide abstract]
  ABSTRACT: In contrast to usual ingredients in processed packaged foodstuffs, there are no suitable and binding regulations for the labeling of unintentional allergen traces in these foods as yet. This situation is unsatisfactory in regard to the fact that even traces of undeclared "hidden" allergens can constitute a considerable health risk for food allergic consumers. Furthermore, the unintentional cross-contact (cross-contamination) of allergens is also an issue in regard to food manufacturer product liability and due diligence. Therefore, stakeholders consider imperative need for the scientific determination of maximum tolerable levels of allergen traces in order to establish thresholds for legally binding food labeling. In addition to conventional toxicological risk assessments, the risk assessment of allergen traces that would be necessary in this context nowadays also incorporates modern approaches such as benchmark procedures and probabilistic modeling and methods. The scientific debate concerning the establishment of safe threshold levels continues, and a consensus must still be reached.
  Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 03/2012; 55(3):394-401. · 0.66 Impact Factor
• Article: [Assessment of allergenicity of genetically modified food crops].

  M Schauzu, A Pöting, D Rubin, A Lampen
  [show abstract] [hide abstract]
  ABSTRACT: The placing on the European Union's market of genetically modified crops requires authorization by the European Commission which is based on the proof that the derived foods are as safe as their conventional counterparts. The assessment of potential allergenicity is part of the necessary investigations recommended in the updated Guidance Document of the Scientific Panel on Genetically Modified Organisms (GMO) of the European Food Safety Authority (EFSA), which is based on internationally agreed recommendations. All genetically modified crops which so far have been authorized in the European Union were evaluated by the EFSA GMO Panel which considered it unlikely that their overall allergenicity has been altered.
  Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 03/2012; 55(3):402-7. · 0.66 Impact Factor